One hypothesis that would be in line with our results is that obesity leads to increasing insulin levels and risk of hyperinsulinemia, which in turns decreases insulin-like growth factor (IGF) binding proteins, thus allowing increasing circulating levels of insulin-like growth factor I (IGF1) (41–43). This evidence concerns the gene INS and obesity disorder.